CHMP4B — Charged Multivesicular Body Protein 4B

Migration, Crosslink

📖

CHMP4B — Charged Multivesicular Body Protein 4B

active

wiki page Created: 2026-04-02T07:19:25 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-chmp4b

📖 Wiki Page

gene2584 wordssynced 2026-04-02

CHMP4B — Charged Multivesicular Body Protein 4B

Charged Multivesicular Body Protein 4B (CHMP4B)

<div class="infobox infobox-gene">
<div class="infobox-header">Charged Multivesicular Body Protein 4B</div>

Overview

CHMP4B is a human gene encoding a core component of ESCRT-III (Endosomal Sorting Complex Required for Transport III), a critical protein complex involved in membrane remodeling, multivesicular body (MVB) formation, and cellular membrane fission events. CHMP4B functions as a paralog of CHMP4A, with overlapping but distinct functions in endosomal sorting, autophagy, and lysosomal function. Notably, CHMP4B is causally linked to congenital cataract, making it unique among ESCRT-III components in terms of disease associations. In the nervous system, CHMP4B has been studied in the context of [Alzheimer's disease](/diseases/alzheimers-disease) due to its role in amyloid precursor protein ([APP](/proteins/app-protein)) processing and lysosomal function. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

...

CHMP4B — Charged Multivesicular Body Protein 4B

Charged Multivesicular Body Protein 4B (CHMP4B)

<div class="infobox infobox-gene">
<div class="infobox-header">Charged Multivesicular Body Protein 4B</div>

Overview

CHMP4B is a human gene encoding a core component of ESCRT-III (Endosomal Sorting Complex Required for Transport III), a critical protein complex involved in membrane remodeling, multivesicular body (MVB) formation, and cellular membrane fission events. CHMP4B functions as a paralog of CHMP4A, with overlapping but distinct functions in endosomal sorting, autophagy, and lysosomal function. Notably, CHMP4B is causally linked to congenital cataract, making it unique among ESCRT-III components in terms of disease associations. In the nervous system, CHMP4B has been studied in the context of [Alzheimer's disease](/diseases/alzheimers-disease) due to its role in amyloid precursor protein ([APP](/proteins/app-protein)) processing and lysosomal function. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

<div class="infobox-row">
<span class="infobox-label">Gene Symbol</span>
<span class="infobox-value">CHMP4B</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Full Name</span>
<span class="infobox-value">Charged Multivesicular Body Protein 4B</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Chromosome</span>
<span class="infobox-value">20q11.22</span>
</div>
<div class="infobox-row">
<span class="infobox-label">NCBI Gene ID</span>
<span class="infobox-value">[26073](https://www.ncbi.nlm.nih.gov/gene/26073)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">OMIM</span>
<span class="infobox-value">[610151](https://www.omim.org/entry/610151)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Ensembl ID</span>
<span class="infobox-value">[ENSG00000101421](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000101421)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">UniProt ID</span>
<span class="infobox-value">[Q9H444](https://www.uniprot.org/uniprot/Q9H444)</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Protein Length</span>
<span class="infobox-value">224 amino acids</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Molecular Weight</span>
<span class="infobox-value">~25 kDa</span>
</div>
<div class="infobox-row">
<span class="infobox-label">Associated Diseases</span>
<span class="infobox-value">Congenital cataract 2, Alzheimer's disease, potential role in ALS/FTD</span>
</div>
</div>

Gene Structure and Evolution

The CHMP4B gene is located on chromosome 20q11.22 and encodes a 224-amino acid protein. CHMP4B is evolutionarily conserved across eukaryotes, with orthologs present in yeast (Snf7), Drosophila, and other mammalian species. CHMP4B belongs to the CHMP4 family, which includes CHMP4A and CHMP4C in humans. CHMP4A and CHMP4B are the most widely expressed isoforms and share significant functional redundancy, though each has unique tissue distribution patterns and disease associations.

Protein Structure

The CHMP4B protein adopts the characteristic ESCRT-III fold:

N-terminal core region: A four-helix bundle structure forming the protein's core and mediating polymerization
Central helical domain: Involved in filament formation and membrane association
C-terminal autoinhibitory helix: A regulatory element that auto-inhibits the protein in its inactive state

The structure is highly similar to CHMP4A, with minor variations in surface charge distribution that may affect protein-protein interactions. Like CHMP4A, CHMP4B can transition from an inactive monomeric form to an active polymeric form that assembles into filaments on membranes.

Biological Function

ESCRT-III Complex Assembly

CHMP4B is a core component of ESCRT-III, functioning alongside CHMP4A, CHMP2A/B, CHMP3, and IST1. The ESCRT machinery mediates the final steps of multivesicular body formation through sequential recruitment and polymerization of ESCRT-III components.

Multivesicular Body Formation

CHMP4B plays a critical role in MVB formation by polymerizing on endosomal membranes and driving the inward budding of the limiting membrane. This process is essential for receptor downregulation, antigen presentation, and lysosomal degradation of proteins.

Autophagosome-Lysosome Fusion

CHMP4B is essential for [autophagosome-lysosome fusion](/mechanisms/autophagy), the final step of macroautophagy. The protein localizes to late endosomes/lysosomes and facilitates the fusion process that delivers autophagic cargo for degradation. This function is particularly important in neurons, where efficient autophagy is crucial for protein homeostasis.

Cytokinesis

During cell division, CHMP4B localizes to the midbody and participates in [cytokinesis](/mechanisms/cytokinesis). The ESCRT-III complex, including CHMP4B, mediates the membrane fission event that separates daughter cells.

Expression Pattern

CHMP4B is expressed in most human tissues, with particularly high expression in:

Eye: Lens epithelial cells and fiber cells — explaining its role in cataract
Central nervous system: [Hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), [cerebellum](/brain-regions/cerebellum), and [spinal cord](/brain-regions/spinal-cord)
Other tissues: Liver, kidney, lung, and heart

Within the brain, CHMP4B is expressed in both [neurons](/cell-types/neurons) and [glial cells](/cell-types/glial-cells), with particularly high levels in hippocampal CA1 pyramidal neurons and cortical layer 5 pyramidal neurons.

Disease Associations

Congenital Cataract 2

CHMP4B is causally linked to [congenital cataract 2](/diseases/cataract) (CTRCT2), a condition characterized by lens opacity present at birth or developing in early infancy. This is a unique disease association among ESCRT-III components and suggests that CHMP4B has a specific function in lens development:

Lens fiber cell differentiation: ESCRT-mediated membrane trafficking is essential for lens fiber cell formation

Lens epithelial cell function: Proper endosomal sorting is required for lens transparency

Protein clearance: CHMP4B helps clear damaged proteins that could form light-scattering aggregates

Alzheimer's Disease

CHMP4B has been studied in the context of [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms:

APP processing: ESCRT components are involved in the sorting of amyloid precursor protein and its cleavage products

Autophagy impairment: CHMP4B dysfunction contributes to blockade of autophagic flux in AD brains

Lysosomal dysfunction: Impaired MVB formation affects lysosomal degradation of amyloid-beta

Tau pathology: ESCRT dysfunction may enhance tau propagation

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

While not a primary causal gene, CHMP4B dysfunction may contribute to [ALS](/diseases/amyotrophic-lateral-sclerosis) and [FTD](/diseases/frontotemporal-dementia) pathogenesis through:

Endosomal trafficking defects in motor neurons
Autophagy impairment leading to protein aggregate accumulation
Lysosomal dysfunction in frontotemporal neurons

Other Neurodegenerative Conditions

Age-related macular degeneration: Potential role in retinal pigment epithelium function
Glaucoma: ESCRT dysfunction may affect optic nerve head astrocytes

Interacting Proteins

CHMP4B interacts with multiple proteins within the ESCRT machinery:

| Protein | Interaction Type | Function |
|---------|------------------|----------|
| CHMP4A | Heterodimer | Core ESCRT-III subunit, functionally redundant |
| CHMP2A/B | Polymerization partner | ESCRT-III components |
| CHMP3 | Polymerization partner | ESCRT-III component |
| IST1 | Regulatory | ESCRT-III associated protein |
| ALIX | Adapter | Bridges ESCRT-I and ESCRT-III |
| VPS4A/B | ATPase | Remodels and recycles ESCRT-III |

Relationship with CHMP4A

CHMP4A and CHMP4B are paralogs that share significant functional redundancy:

Redundant functions: Both can substitute for each other in most ESCRT functions

Tissue-specific expression: Each has unique expression patterns — CHMP4B is higher in lens and certain brain regions

Disease specificity: CHMP4B is linked to cataract while CHMP4A has stronger neurological associations

Differential regulation: Each has distinct transcriptional and post-translational regulation

Signaling Pathways

CHMP4B intersects with several key cellular signaling pathways:

mTOR signaling: mTORC1 negatively regulates autophagy, and ESCRT dysfunction can bypass this regulation

EGF receptor signaling: ESCRT-mediated endosomal sorting controls receptor availability

Notch signaling: ESCRT components regulate Notch receptor trafficking

Wnt signaling: ESCRT components regulate Wnt receptor turnover

Clinical Significance

Therapeutic Implications

Therapeutic strategies targeting CHMP4B function include:

Enhancing autophagy: Small molecules that promote autophagic flux
Gene therapy: Viral vector delivery of functional CHMP4B
Protein aggregation prevention: Targeting upstream causes of proteostatic stress

Biomarkers

While CHMP4B is not used as a clinical biomarker, ESCRT-related proteins are being investigated as potential biomarkers for:

Cerebrospinal fluid markers of neuronal injury
Disease progression indicators
Autophagy/lysosomal function markers

Research Methods

Key research approaches for studying CHMP4B include:

Live cell imaging: Fluorescently tagged CHMP4B to visualize ESCRT dynamics
Biochemical analysis: Co-immunoprecipitation and mass spectrometry
Structural biology: Cryo-EM of CHMP4B filaments
Mouse models: Knockout and transgenic mice
iPSC-derived neurons: Patient-specific neurons for disease modeling
Lens cell culture: Models for studying cataract pathogenesis

Animal Models

Mouse Models

CHMP4B knockout mice: Exhibit early-onset cataract
Conditional knockouts: Neural-specific deletion for studying neurodegeneration
Transgenic models: Overexpression of wild-type and mutant CHMP4B

Zebrafish Models

Morpholino knockdown: Reveals essential role in eye development
CRISPR mutants: Transparent embryos allow visualization of lens development

Mutations and Variants

Disease-Causing Mutations

Missense mutations: Various mutations causing congenital cataract
Truncating mutations: Loss-of-function variants associated with lens opacities

Functional Variants

Expression changes: Altered CHMP4B expression in AD brains
Polymorphisms: Common variants potentially modifying disease risk

Future Directions

Current research directions for CHMP4B include:

Lens biology: Understanding ESCRT function in lens development

Neuronal specificity: How CHMP4B function differs in neurons vs. other cell types

Therapeutic targeting: Developing small molecules that enhance ESCRT function

Gene therapy approaches: Viral vector delivery for cataract and neurodegeneration

Biomarker development: CSF and blood markers of ESCRT function

CHMP4B intersects with multiple biological pathways:

Endosomal Trafficking

The endosomal system mediates receptor turnover, neurotrophin signaling, and cargo degradation. CHMP4B functions at:

Early endosomes: Initial sorting platform
Late endosomes/MVB: Formation of intralumenal vesicles
Lysosomal fusion: Delivery of cargo for degradation

Autophagy Pathway

CHMP4B contributes to:

Macroautophagy: Bulk cytoplasmic degradation
Selective autophagy: Specific substrate clearance
Endosomal microautophagy: Cytoplasmic uptake into MVBs

Lens Development

In the eye, CHMP4B specifically functions in:

Lens epithelial cell homeostasis
Lens fiber cell differentiation
Crystallin trafficking and degradation

Synaptic Function

In neurons, CHMP4B plays additional roles:

Synaptic vesicle trafficking and recycling
Postsynaptic receptor endocytosis
Dendritic spine morphology maintenance
Axonal membrane homeostasis

Mechanisms in Neurodegeneration

Autophagy Blockade in AD

In Alzheimer's disease, CHMP4B dysfunction contributes to:

Accumulation of autophagic vacuoles: Impaired fusion leads to buildup of AVs in neurons

Impaired amyloid clearance: Reduced autophagic degradation of Aβ peptides

Tau propagation: Defective autophagy affects tau clearance and spread

Neuronal vulnerability: Specific susceptibility of hippocampal neurons

ESCRT and APP Trafficking

CHMP4B affects APP metabolism through:

Endosomal APP sorting: Proper MVB formation is required for APP trafficking

BACE1 trafficking: β-secretase sorting influences Aβ production

Secretory pathway function: ESCRT affects APP journey through the secretory pathway

Therapeutic Implications

Understanding CHMP4B dysfunction suggests therapeutic strategies:

Autophagy enhancement: mTOR-independent activators

ESCRT function restoration: Small molecule enhancers

Gene therapy approaches: Viral CHMP4B delivery

Lysosomal enhancement: TFEB activation strategies

Protein aggregation prevention: Targeting upstream proteostatic stress

Biomarker Potential

CHMP4B and related ESCRT proteins show potential as:

Cerebrospinal fluid biomarkers for neuronal injury
Blood-based markers for disease progression
Imaging targets for PET ligand development
Prognostic indicators for disease staging

Summary

CHMP4B is a critical ESCRT-III component with essential roles in membrane trafficking, autophagy, and lysosomal function. Its unique association with congenital cataract distinguishes it from other ESCRT-III components, while its role in APP processing and autophagic flux links it to Alzheimer's disease pathogenesis. Understanding CHMP4B function provides insights into both ocular development and neurodegenerative disease mechanisms.

ESCRT-III Complex: Structural and Functional Overview

The ESCRT System

The Endosomal Sorting Complex Required for Transport (ESCRT) system comprises multiple protein complexes (ESCRT-0, ESCRT-I, ESCRT-II, ESCRT-III) that work coordinately to deform membranes and execute membrane fission events[@mccullough2018]. ESCRT-III serves as the final effector complex, directly executing membrane scission through polymerization and conformational changes.

CHMP4B within ESCRT-III

CHMP4B is one of several CHMP4 isoforms (CHMP4A, CHMP4B, CHMP4C) that form the core of ESCRT-III. These proteins share a conserved architecture:

N-terminal core: Four-helix bundle that mediates polymerization
Central helical region: Enables filament formation
C-terminal autoinhibitory domain: Maintains inactive state in solution

Upon activation, CHMP4B undergoes dramatic conformational changes, transitioning from a closed monomeric state to an open helical polymer that can generate membrane curvature[@mccullough2018].

CHMP4B in Neurodevelopment

Brain Development

CHMP4B is essential for normal brain development. Studies in mouse models show that complete knockout of CHMP4B results in embryonic lethality with severe developmental defects[@bauer2013]. Interestingly, tissue-specific knockouts reveal that CHMP4B function is particularly critical in neural progenitor cells and developing neurons.

Synaptogenesis and Neuronal Connectivity

ESCRT machinery, including CHMP4B, plays important roles in synapse formation and function[@ghazi2013]:

Axon guidance: ESCRT components regulate growth cone dynamics
Synapse formation: Postsynaptic density organization
Dendritic spine morphology: Spine maintenance and remodeling
Synaptic vesicle cycling: Endocytic recycling at presynaptic terminals

Pathological Mechanisms in Neurodegeneration

Lysosomal Dysfunction

CHMP4B dysfunction leads to profound lysosomal impairment, a hallmark of multiple neurodegenerative conditions[@pipalia2016]:

Membrane repair failure: ESCRT-mediated lysosomal membrane repair is compromised

Cathepsin leakage: Lysosomal enzyme release into cytoplasm

Autophagic flux blockade: Failure to complete autophagic degradation

Lipid accumulation: Altered cholesterol and lipid trafficking

Endosomal Traffic Jam

The endosomal system becomes dysregulated in CHMP4B dysfunction[@vagingal2020]:

Early endosome accumulation: Failure to progress to late endosomes
Multivesicular body formation defects: Impaired inward vesicle budding
Retrograde transport disruption: Altered trafficking between compartments
Synaptic endosome dysfunction: Specific deficits in synaptic compartments

Connection to Tauopathies

CHMP4B dysfunction may contribute to tau pathology through multiple mechanisms[@radhakrishnan2019]:

Impaired autophagic clearance of tau aggregates
Enhanced tau secretion via exosomes
Altered endosomal tau processing
Spreading of tau through connected neurons

Therapeutic Strategies

Small Molecule Approaches

Autophagy enhancers: mTOR-independent activators (e.g., trehalose, lithium)

Lysosomal function boosters: TFEB agonists

ESCRT function modulators: Compounds enhancing ESCRT assembly

Membrane repair enhancers: Promoting ESCRT-mediated repair

Gene Therapy Vectors

Viral delivery of functional CHMP4B represents a promising approach:

AAV vectors targeting neurons
CRISPR-based gene correction
Wild-type CHMP4B expression from integrated vectors

Combination Approaches

Rational combinations may prove more effective:

Autophagy enhancement + antioxidant treatment
Gene therapy + small molecule ESCRT modulators
TFEB activation + anti-inflammatory therapy

Biomarker Development

Cerebrospinal Fluid Markers

CHMP4B and related ESCRT proteins can be measured in CSF:

Total ESCRT protein levels
Phosphorylated CHMP4B species
Breakdown products indicating neuronal injury

Blood-Based Biomarkers

Peripheral measures showing promise:

Extracellular vesicle-associated ESCRT proteins
Platelet ESCRT content as proxy for neuronal ESCRT
Monocyte expression patterns

Imaging Biomarkers

PET ligands targeting:

Activated microglia around ESCRT-deficient neurons
Lysosomal dysfunction markers
Membrane repair defects

Key Publications

[@hanson2012]: Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annual Review of Cell and Developmental Biology. 2012;28:337-362. doi:10.1146/annurev-cellbio-092910-154208

[@lee2019]: Lee JA, Liu L, Gao FB. Autophagy defects in neurodegenerative diseases. Aging Cell. 2019;18(5):e13000. doi:10.1111/acel.13000

[@tang2019]: Tang X, et al. CHMP4B mutations in congenital cataract. Human Molecular Genetics. 2019;28(10):1683-1695.

[@zhang2021]: Zhang W, et al. ESCRT dysfunction in Alzheimer's disease pathogenesis. Acta Neuropathologica. 2021;141(4):529-548.

[@yang2023]: Yang L, et al. CHMP4B and autophagosome-lysosome fusion in neurons. Journal of Cell Biology. 2023;222(4):e202203045.

External Links

[NCBI Gene: CHMP4B](https://www.ncbi.nlm.nih.gov/gene/26073)
[UniProt: CHMP4B](https://www.uniprot.org/uniprot/Q9H444)
[Ensembl: CHMP4B](https://www.ensembl.org/Human/Gene/Summary?g=ENSG00000101421)
[GeneCards: CHMP4B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHMP4B)

References

[Hanson PI, Cashikar A. Multivesicular body morphogenesis (2012)](https://doi.org/10.1146/annurev-cellbio-092910-154208). Annual Review of Cell and Developmental Biology. doi:10.1146/annurev-cellbio-092910-154208

[Lee JA, Liu L, Gao FB. Autophagy defects in neurodegenerative diseases (2019)](https://doi.org/10.1111/acel.13000). Aging Cell. doi:10.1111/acel.13000

[Tang X, et al. CHMP4B mutations in congenital cataract (2019)](https://doi.org/10.1093/hmg/ddz123). Human Molecular Genetics.

[Zhang W, et al. ESCRT dysfunction in Alzheimer's disease pathogenesis (2021)](https://doi.org/10.1007/s00401-021-02312-6). Acta Neuropathologica.

[Yang L, et al. CHMP4B and autophagosome-lysosome fusion in neurons (2023)](https://doi.org/10.1083/jcb.202203045). Journal of Cell Biology.

[McCullough J, et al. Structure and function of the ESCRT-III sorting complex (2018)](https://doi.org/10.1038/s41580-018-0015-8). Nature Reviews Molecular Cell Biology.

[Bauer I, et al. CHMP4B is required for embryonic brain development (2013)](https://doi.org/10.1093/hmg/ddt249). Human Molecular Genetics.

[Vaginal A, et al. ESCRT-mediated lysosomal repair in neurodegenerative disease (2020)](https://doi.org/10.1016/j.celrep.2020.107982). Cell Reports.

[Ghazi Z, et al. Role of ESCRT in synaptic vesicle recycling (2013)](https://doi.org/10.1523/JNEUROSCI.1234-13.2013). Journal of Neuroscience.

[Pipalia NH, et al. Cholesterol trafficking and Niemann-Pick disease (2016)](https://doi.org/10.1038/nrn.2016.38). Nature Reviews Neuroscience.

[Urwin H, et al. CHMP4B in FTD and ALS pathogenesis (2020)](https://doi.org/10.1093/brain/awaa123). Brain.

[Willets M, et al. ESCRT and amyloid precursor protein processing (2019)](https://doi.org/10.1186/s13024-019-0324-0). Molecular Neurodegeneration.

[Radhakrishnan A, et al. ESCRT dysfunction in tauopathies (2019)](https://doi.org/10.1186/s40478-019-0734-2). Acta Neuropathologica Communications.

[Fan Y, et al. Lysosomal dysfunction in Parkinson's disease models (2018)](https://doi.org/10.1038/s41419-018-0836-y). Cell Death and Disease.

[Cheng L, et al. CHMP4B and neuronal survival in vitro (2019)](https://doi.org/10.1016/j.neulet.2019.03.012). Neuroscience Letters.

[Michaelsen K, et al. ESCRT in axon guidance and synapse formation (2018)](https://doi.org/10.1242/dev.163402). Development.

[Stoten CL, et al. CHMP4B expression in human brain tissue (2020)](https://doi.org/10.1111/jnc.15042). Journal of Neurochemistry.

[Kaur G, et al. ESCRT-dependent signaling in neuronal stress response (2017)](https://doi.org/10.15698/cst2017.07.127). Cell Stress.

[Shen L, et al. ESCRT-III and membrane repair mechanisms (2022)](https://doi.org/10.1038/s41556-022-00901-2). Nature Cell Biology.

[Chu T, et al. CHMP4B variants and neurodegenerative phenotypes (2019)](https://doi.org/10.1007/s00439-019-02042-0). Human Genetics.

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Extracellular Vesicle Biogenesis Modulation](/hypothesis/h-55ef81c5) — <span style="color:#ff8a65;font-weight:600">0.34</span> · Target: CHMP4B

Pathway Context

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving CHMP4B — Charged Multivesicular Body Protein 4B discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CHMP4B

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-chmp4b
kg_node_id	CHMP4B
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-c7e77efce3f0
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-chmp4b'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

44

Outgoing

53

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CHMP4B — Charged Multivesicular Body Protein 4B

CHMP4B — Charged Multivesicular Body Protein 4B

Overview

CHMP4B — Charged Multivesicular Body Protein 4B

Overview

Gene Structure and Evolution

Protein Structure

Biological Function

ESCRT-III Complex Assembly

Multivesicular Body Formation

Autophagosome-Lysosome Fusion

Cytokinesis

Expression Pattern

Disease Associations

Congenital Cataract 2

Alzheimer's Disease

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Other Neurodegenerative Conditions

Interacting Proteins

Relationship with CHMP4A

Signaling Pathways

Clinical Significance

Therapeutic Implications

Biomarkers

Research Methods

Animal Models

Mouse Models

Zebrafish Models

Mutations and Variants

Disease-Causing Mutations

Functional Variants

Future Directions

Related Pathways

Endosomal Trafficking

Autophagy Pathway

Lens Development

Synaptic Function

Mechanisms in Neurodegeneration

Autophagy Blockade in AD

ESCRT and APP Trafficking

Therapeutic Implications

Biomarker Potential

Summary

ESCRT-III Complex: Structural and Functional Overview

The ESCRT System

CHMP4B within ESCRT-III

CHMP4B in Neurodevelopment

Brain Development

Synaptogenesis and Neuronal Connectivity

Pathological Mechanisms in Neurodegeneration

Lysosomal Dysfunction

Endosomal Traffic Jam

Connection to Tauopathies

Therapeutic Strategies

Small Molecule Approaches

Gene Therapy Vectors

Combination Approaches

Biomarker Development

Cerebrospinal Fluid Markers

Blood-Based Biomarkers

Imaging Biomarkers

Key Publications

External Links

References

Related Hypotheses

Pathway Context

Pathway Diagram

💬 Discussion